James N. Moy

3.6k total citations
57 papers, 1.3k citations indexed

About

James N. Moy is a scholar working on Immunology, Physiology and Infectious Diseases. According to data from OpenAlex, James N. Moy has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 13 papers in Physiology and 11 papers in Infectious Diseases. Recurrent topics in James N. Moy's work include Immunodeficiency and Autoimmune Disorders (13 papers), Asthma and respiratory diseases (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). James N. Moy is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (13 papers), Asthma and respiratory diseases (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). James N. Moy collaborates with scholars based in United States, Germany and Poland. James N. Moy's co-authors include Larry L. Thomas, Laura Rocco Carpenter, Kenneth A. Roebuck, Venkatesh Lakshminarayanan, Evalyn N. Grant, G J Gleich, Kevin B. Weiss, Steven R. Daugherty, John M. Keller and Mark E. Peeples and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

James N. Moy

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James N. Moy United States	19	395	334	303	201	182	57	1.3k
Ahmet Özen Türkiye	21	701 1.8×	284 0.9×	185 0.6×	175 0.9×	145 0.8×	103	1.6k
Wen‐I Lee Taiwan	19	438 1.1×	164 0.5×	146 0.5×	138 0.7×	226 1.2×	66	1.0k
Peter H. Hoeger Germany	26	450 1.1×	333 1.0×	95 0.3×	236 1.2×	200 1.1×	74	2.8k
Thomas P. Duffy United States	22	635 1.6×	223 0.7×	194 0.6×	325 1.6×	160 0.9×	76	1.9k
Liang-Shiou Ou Taiwan	19	446 1.1×	428 1.3×	204 0.7×	146 0.7×	128 0.7×	67	1.4k
Ryo Sumazaki Japan	24	305 0.8×	145 0.4×	132 0.4×	482 2.4×	393 2.2×	105	1.9k
F. Eun-Hyung Lee United States	12	709 1.8×	692 2.1×	433 1.4×	249 1.2×	141 0.8×	24	1.7k
Young Mok Lee South Korea	20	343 0.9×	500 1.5×	364 1.2×	159 0.8×	149 0.8×	43	1.1k
Stefano Del Giacco Italy	20	207 0.5×	548 1.6×	366 1.2×	133 0.7×	94 0.5×	79	1.5k
Kousaku Matsubara Japan	26	274 0.7×	118 0.4×	301 1.0×	386 1.9×	485 2.7×	108	2.0k

Countries citing papers authored by James N. Moy

Since Specialization

Citations

This map shows the geographic impact of James N. Moy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James N. Moy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James N. Moy more than expected).

Fields of papers citing papers by James N. Moy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James N. Moy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James N. Moy. The network helps show where James N. Moy may publish in the future.

Co-authorship network of co-authors of James N. Moy

This figure shows the co-authorship network connecting the top 25 collaborators of James N. Moy. A scholar is included among the top collaborators of James N. Moy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James N. Moy. James N. Moy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adeniji, Opeyemi S., Devivasha Bordoloi, Jeff Martinson, et al.. (2023). Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. mBio. 14(1). e0339322–e0339322. 9 indexed citations

Chen, Chen, Sairam Parthasarathy, Jacqueline M. Leung, et al.. (2023). Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infection. Frontiers in Medicine. 10. 1227883–1227883. 4 indexed citations

Kriván, Gergely, Michael Borte, Pere Soler‐Palacín, et al.. (2022). BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children. Journal of Clinical Immunology. 43(3). 557–567. 2 indexed citations

Anderson, Mark, et al.. (2021). SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine. JAMA Network Open. 4(8). e2119741–e2119741. 32 indexed citations

Adeniji, Opeyemi S., Leila B. Giron, Mansi Purwar, et al.. (2021). COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 12(2). 45 indexed citations

Codispoti, Christopher D., et al.. (2020). Running a virtual allergy division and training program in the time of COVID-19 pandemic. Journal of Allergy and Clinical Immunology. 145(5). 1357–1359. 18 indexed citations

Moy, James N., et al.. (2020). M005 TPN HYPERSENSITIVITY CAUSING RECURRENT URTICARIA IN A PREMATURE NEONATE WITH GASTROSCHISIS. Annals of Allergy Asthma & Immunology. 125(5). S55–S55.

Wasserman, Richard L., Againdra K. Bewtra, James N. Moy, et al.. (2009). C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2). Journal of Allergy and Clinical Immunology. 123(2). S99–S99. 3 indexed citations

Kumar, Rajesh, Laura M. Curtis, James N. Moy, et al.. (2008). A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago. Journal of Allergy and Clinical Immunology. 122(4). 754–759.e1. 44 indexed citations

10.

Moy, James N., et al.. (2003). Association of recurrent wheezing with sensitivity to cockroach allergen in inner-city children. Annals of Allergy Asthma & Immunology. 91(5). 455–459. 17 indexed citations

11.

Carpenter, Laura Rocco, James N. Moy, & Kenneth A. Roebuck. (2002). Respiratory syncytial virus and TNFalpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappaB1. BMC Infectious Diseases. 2(1). 5–5. 37 indexed citations

12.

Grant, Evalyn N., et al.. (2001). Cockroach allergy appears early in life in inner-city children with recurrent wheezing. Annals of Allergy Asthma & Immunology. 86(1). 51–54. 27 indexed citations

13.

Sylvia, Lynne M., et al.. (2000). Interactive Video Conferencing for the Small College: Pitfalls and Possibilities. EdMedia: World Conference on Educational Media and Technology. 2000(1). 636–643. 2 indexed citations

14.

Peeples, Mark E., et al.. (1999). Respiratory Syncytial Virus Stimulates Neutrophil Degranulation and Chemokine Release. The Journal of Immunology. 163(5). 2816–2820. 106 indexed citations

15.

Grant, Evalyn N., et al.. (1999). Asthma Care Practices, Perceptions, and Beliefs of Chicago-Area Primary-Care Physicians. CHEST Journal. 116(4 Suppl 1). 145S–154S. 52 indexed citations

16.

Moy, James N., et al.. (1999). Asthma Care Practices, Perceptions, and Beliefs of Chicago-Area Asthma Specialists. CHEST Journal. 116(4 Suppl 1). 154S–162S. 23 indexed citations

17.

Grant, Evalyn N., et al.. (1999). Prevalence and burden of illness for asthma and related symptoms among kindergartners in Chicago public schools. Annals of Allergy Asthma & Immunology. 83(2). 113–120. 69 indexed citations

18.

McGrogan, Michael, D A Loegering, James L. Checkel, et al.. (1995). Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein. The Journal of Immunology. 155(3). 1472–1480. 25 indexed citations

19.

Moy, James N., G J Gleich, & Larry L. Thomas. (1990). Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.. The Journal of Immunology. 145(8). 2626–2632. 83 indexed citations

20.

Keller, John M., et al.. (1980). Heparan sulfates from Swiss mouse 3T3 and SV3T3 cells: O-sulfate difference. Biochemistry. 19(11). 2529–2536. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact